Synthesis and Biological Evaluation of Clovamide Analogues As Potent Anti-Neuroinflammatory Agents in Vitro and in Vivo

Xiao-Long Hu,Jun Lin,Xian-Yu Lv,Jia-Hao Feng,Xiao-Qi Zhang,Hao Wang,Wen-Cai Ye
DOI: https://doi.org/10.1016/j.ejmech.2018.03.081
IF: 7.088
2018-01-01
European Journal of Medicinal Chemistry
Abstract:A series of clovamide analogues, namely, 1a-13a and 1b-13b, was synthesized and evaluated for their anti-neuroinflammatory activities using BV-2 microglia cells. Among these compounds, six (1b, 4b-8b) showed NO inhibition with no or weak cytotoxicity (CC50 > 100 mu M), especially 4b, and showed an IC50 value of 2.67 mu M. Enzyme activity and docking assay revealed that the six compounds, especially 4b, target inducible NO synthase (iNOS) and exhibit potent inhibitory effects on iNOS with IC50 values ranging from 1.01 mu M to 29.23 mu M 4b significantly suppressed the expression of pro-inflammatory cytokines in lipopolysaccharide-stimulated cells. Notably, the oral administration of 4b remarkably improved dyskinesia, reduced the expression of glial fibrillary acidic protein (GFAP)-a marker of neuroinflammation, and increased tyrosine hydroxylase-positive cells in 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine-induced Parkinson's disease (PD) mouse models. These observations demonstrated that 4b is an effective and promising candidate for PD therapy. (C) 2018 Elsevier Masson SAS. All rights reserved.
What problem does this paper attempt to address?